Selenium supplementation and gestational diabetes: A randomised controlled trial

dc.contributor.authorYiğit, Ece
dc.contributor.authorSayar, İlknur
dc.date.accessioned2024-05-30T08:27:15Z
dc.date.available2024-05-30T08:27:15Z
dc.date.issued2024
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractObjective: To assess the effects of selenium supplementation on blood glucose levels in women with gestational diabetes mellitus (GDM). Study Design: Randomised controlled trial. Place and Duration of the Study: Department of Internal Medicine, Istanbul Medipol University, Faculty of Medicine, Istanbul, Turkiye, from February to July 2023. Methodology: In the first phase of this study, the selenium levels of the pregnant women who routinely had an oral glucose tolerance test were measured, and in the second phase of the study, the pregnant women diagnosed with GDM were randomly divided into two groups that received 4-week interventions: Diet alone and diet plus selenium supplementation (200 ?g/day). Results: Selenium level in pregnant women with GDM was significantly lower than in healthy pregnant women, and a selenium level less than 80 ng/ml predicted GDM diagnosis with a sensitivity of 58.59% and a specificity of 67.11%. Pregnant women with low selenium (<80 ng/ml) had a 2.709-fold higher risk for GDM compared to those with higher values. Fasting blood glucose levels decreased significantly in both groups after the respective interventions, but the decrease was greater in selenium recipients. Furthermore, fasting, 1st and 2nd hour blood glucose levels were lower in selenium recipients compared to those who only received diet. Conclusion: Selenium level in pregnant women with GDM was low compared to healthy pregnant women. Selenium supplementation had a beneficial impact (compared to diet only) on blood glucose levels in pregnant women with GDM.
dc.identifier.citationYiğit, E. ve Sayar, İ. (2024). Selenium supplementation and gestational diabetes: A randomised controlled trial. Journal of the College of Physicians and Surgeons Pakistan, 34(5), 561-567. http://dx.doi.org/10.29271/jcpsp.2024.05.561
dc.identifier.doi10.29271/jcpsp.2024.05.561
dc.identifier.endpage567
dc.identifier.issn1022-386X
dc.identifier.issn1681-7168
dc.identifier.issue5
dc.identifier.pmid38720217
dc.identifier.scopus2-s2.0-85192609644
dc.identifier.scopusqualityQ3
dc.identifier.startpage561
dc.identifier.urihttp://dx.doi.org/10.29271/jcpsp.2024.05.561
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12539
dc.identifier.volume34
dc.identifier.wos001245516800012en_US
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorYiğit, Ece
dc.language.isoen
dc.relation.ispartofJournal of the College of Physicians and Surgeons Pakistanen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDiabetes
dc.subjectDietary Supplements
dc.subjectGestational
dc.subjectPregnancy
dc.subjectPregnancy Outcome
dc.subjectSelenium
dc.titleSelenium supplementation and gestational diabetes: A randomised controlled trial
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Yiğit-Ece-2024.pdf
Boyut:
2.12 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: